Clinical trial
Siltuximab in Schizophrenia
NCT02796859
Study timeline
Study start (unknown)2016-05-01Date precision: month
Registry last updated2023-07-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Psychotic Disordersunresolved
Interventions
SiltuximabDRUG
normal salineDRUG
Sponsors & collaborators
Brian Millerlead sponsor
Stanley Medical Research Institutecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02796859 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.